The Food and Drug Administration (FDA) has approved additional changes to the Ortho Evra Contraceptive Transdermal (Skin) Patch label to include the results of a new epidemiology study that found that users of the birth control patch were at higher risk of developing serious blood clots, also known as venous thromboembolism (VTE), than women using birth control pills. VTE can lead to pulmonary embolism.
more .... http://www.fda.gov/bbs/topics/NEWS/2008/NEW01781.html
Posted by Louisville, Kentucky lawyer: Larry Jones 1-888-KYLAW22
